Kameel D. Farag - Interim CFO at Akari Therapeutics Plc

Insider Transactions and Holdings

Entity Type
Individual
Role
Interim CFO
Stock Symbol
AKTX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kameel D. Farag since 12/6/2024

Holdings reported by Kameel D. Farag for Akari Therapeutics Plc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
American Depositary Shares representing Ordinary Shares 26.6K $20K $0.75 Nov 1, 2025 Direct

Transactions reported by Kameel D. Farag for Akari Therapeutics Plc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.